Metacrine to Present at 2021 Canaccord Genuity Growth Conference
09-Aug-2021 12:05:00 | Yahoo Sports
SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced that Preston Klassen, M.D., MHS, president and chief executive officer, will present virtually at the 2021 Canaccord Genuity Growth Conference at 12:30 p.m. ET on Thursday, August 12, 2021. A live webcast of the presentation will be available at https://investors.metacrine.
Read More